Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 25, 2025Frontiers in PediatricsOpen Access

Remimazolam in pediatric anesthesia: a systematic review for clinical decision-making

View Full Paper
Ask AI
Bookmark
Share

Authors

YZYi ZhangQCQiuxiang ChenShenzhen University Health Science CenterLWLinyun Wang

Discussion

Loading...

Member takes

Implication

Systematic review shows remimazolam's improved hemodynamic stability and reduced emergence delirium in pediatric patients, suggesting its clinical advantages.

Key Points

  • Remimazolam significantly reduces emergence delirium by 61% compared to propofol, indicating its effectiveness.
  • Involving 2,847 pediatric patients across 23 studies, the review emphasizes robust evidence supporting remimazolam's safety profile.
  • Following PRISMA guidelines, the systematic review evaluates the advantages and limitations of remimazolam in pediatric anesthesia.
  • The lack of long-term neurodevelopmental safety data highlights the need for further research before wider adoption.

Cite This Study

Zhang et al. (2025) studied this question.

synapsesocial.com/papers/68d5bd72dc445aa9033b0ba9https://doi.org/10.3389/fped.2025.1662752
View Full Paper
Ask AI
Bookmark
Share